Pharmaceutical composition comprising propofol
AssigneeNovaliq GmbH
InventorsBastian Theisinger, Sonja Theisinger
Life of this patent
Estimating the term…
Abstract
The invention provides novel pharmaceutical compositions comprising the active ingredient propofol. Preferably, propofol is dissolved in at least one semifluorinated alkane. The compositions, which are preferably liquid or gel-like, may optionally comprise further excipients. They may be used as fill material in capsules, as buccal or nasal sprays, or as aerosols for pulmonary administration. They are particularly useful for the transmucosal administration of propofol.
Claims17
A pharmaceutical composition comprising a therapeutically effective amount of propofol and a semifluorinated alkane.
The composition of any preceding claim, wherein the concentration of propofol is about 1 wt.-% or higher.
The composition of any preceding claim, wherein essentially all of the propofol comprised therein is in dissolved form.
The composition of any preceding claim, being in the form of a liquid or a gel.
The composition of any preceding claim, being substantially free of lipids such as trigylcerides or phospholipids.
Dependencies are inferred from the claim text.